Paracelsus Medizinische Privatuniversität (PMU)

Research & Innovation
Publications

Endothelin-1 genetic polymorphism (SNP rs5370-TT) fails to predict resistance to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial

#2022
#ANNALS OF ONCOLOGY

PMU Authors
Simon Peter Gampenrieder, Markus Steiner, Clemens Hufnagl, Gabriel Rinnerthaler, Florian Huemer, Patrick Morre, Cornelia Hauser-Kronberger, Richard Greil

All Authors
Simon Peter Gampenrieder, Markus Steiner, Clemens Hufnagl, H. Hackl, Gabriel Rinnerthaler, T. Westphal, Florian Huemer, C. Monzo-Fuentes, Patrick Morre, Cornelia Hauser-Kronberger, Richard Greil

Journal association
ANNALS OF ONCOLOGY

Abstract